Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/105795
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Falcon Neyra, Lola | - |
dc.contributor.author | Benmarzouk-Hidalgo, Omar J. | - |
dc.contributor.author | Madrid, Lola | - |
dc.contributor.author | Noguera Julian, Antoni | - |
dc.contributor.author | Fortuny Guasch, Claudia | - |
dc.contributor.author | Neth, Olaf | - |
dc.contributor.author | López Cortés, Luis F. | - |
dc.date.accessioned | 2017-01-18T16:35:40Z | - |
dc.date.available | 2017-01-18T16:35:40Z | - |
dc.date.issued | 2015-03 | - |
dc.identifier.issn | 0025-7974 | - |
dc.identifier.uri | http://hdl.handle.net/2445/105795 | - |
dc.description.abstract | This is a cross-sectional study of 15 aviremic chronic HIV-infected children revealing no differences in immune activation (IA; HLA-DRCD38 CD4 and CD8 T cells, and sCD14) and microbial translocation (MT; lipopolysaccharides (LPS) and 16S rDNA) among HIV-infected patients under combined antiretroviral treatment (cART; n = 10) or ritonavir-boosted protease inhibitor monotherapy (mtPI/rtv; n = 5). In both cases, IA and MT were lower in healthy control children (n = 32). This observational study suggests that ritonavir boosted protease inhibitor monotherapy (mtPI/rtv) is not associated with an increased state of IA or MT as compared with children receiving cART. | - |
dc.format.extent | 4 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Lippincott, Williams & Wilkins. Wolters Kluwer Health | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1097/MD.0000000000000521 | - |
dc.relation.ispartof | Medicine, 2015, vol. 94, num. 11, p. e521 | - |
dc.relation.uri | https://doi.org/10.1097/MD.0000000000000521 | - |
dc.rights | cc-by (c) Falcon-Neyra, L. et al., 2015 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | - |
dc.source | Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques) | - |
dc.subject.classification | Infants | - |
dc.subject.classification | Infeccions per VIH | - |
dc.subject.classification | Antiretrovirals | - |
dc.subject.classification | Inhibidors enzimàtics | - |
dc.subject.other | Children | - |
dc.subject.other | HIV infections | - |
dc.subject.other | Antiretroviral agents | - |
dc.subject.other | Enzyme inhibitors | - |
dc.title | No differences of immune activation and microbial translocation among HIV-infected children receiving combined antiretroviral therapy or protease inhibitor monotherapy. | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 660358 | - |
dc.date.updated | 2017-01-18T16:35:41Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 25789946 | - |
Appears in Collections: | Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques) Articles publicats en revistes (ISGlobal) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
660358.pdf | 150.54 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License